Gender | Baseline | Incidence assessment at 28Â weeks | ||||||
---|---|---|---|---|---|---|---|---|
 | 1st Screening | 2nd Screening | Prepatent Infection | Negative | Screened | Attrition Rate | Negative | New Infection |
Female | 126 | 108 | 7 (6.4) | 101 (93.6) | 62 | 39 (36.1) | 59 (95.2) | 3 (4.8) |
Male | 74 | 63 | 6 (9.5) | 57 (90.5) | 34 | 25 (39.7) | 33 (95.0) | 1 (3.0) |
Total | 200 | 171 | 13 (7.6) | 158 (92.4) | 96 | 64 (37.4) | 92 (95.9) | 4 (4.1) |